Date: 14 July 2022
Country: Webinar
Programme & Speakers:
Introduction - Toni Seppälä (Finland)
MSI Biology and Pathology - John Burn (UK)
Implications of MSI for surgeons - Gabriela Möslein (Germany)
Oncological implications: when is immunotherapy an option? - Kai-Keen Shiu (UK)
Discussions and Live Q&A
Commentator:
Des Winter (Ireland)
Moderator:
Toni Seppälä (Finland)
Who is this event intended for?
Colorectal surgeons and those interested in personalised therapy and hereditary cancer
What is the benefit of attending?
Understanding the importance of microsatellite instability testing.
Supported by the European Hereditary Tumour Group
Sponsored by Promega